US arms sales rebound back to $50B in fiscal 2022
US arms sales to allies and partners bounced back with a total of about $50 billion in sales cases cleared in fiscal 2022, a big jump from the total of about $35 billion last year.
two other major factors also likely influenced sales. First, similar to the increased interest from European countries, there has been a wave of sales from partners in the Indo-Pacific who recognize the threat of China and are moving to recapitalize their legacy system.
https://breakingdefense.com/2022/09/with-russian-industrial-base-in-shambles-us-looks-for-arms-sale-opportunities/
With Russian industrial base in shambles, US looks for arms sale ‘opportunities’
Russia’s invasion of Ukraine and the resulting conflict has shattered the Russian defense industrial base, leaving the second biggest provider of arms in the world far less capable of selling them abroad. Now the question US officials are examining is whether the US can exploit that weakness for its own strategic benefit.
The sanctions and the export controls that the United States and our allies and partners around the world have imposed upon Russia are going to have long-lasting consequences on the Russian industrial defense industrial base.
In another move meant to reduce Russia’s status as a major arms provider, the State Department earlier this month announced plans to provide $2.2 billion in Foreign Military Financing available to Ukraine and 17 other European nations. A total of $1 billion would be earmarked specifically for Ukraine, with the remaining funds made available to Albania, Bosnia and Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Greece, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Slovakia and Slovenia.
- Forums
- World Politics
- Russia Ukraine war
Russia Ukraine war, page-65096
-
- There are more pages in this discussion • 164,135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online